Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors Read more about Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors Read more about Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) Read more about Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-I Read more about A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-I
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants Read more about Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Updated Diagnostic Cortisol Values for Adrenal Insufficiency Read more about Updated Diagnostic Cortisol Values for Adrenal Insufficiency
Time Course for Fasting-induced Autophagy in Humans Read more about Time Course for Fasting-induced Autophagy in Humans
Diabetes Prevention Program Outcomes Study Read more about Diabetes Prevention Program Outcomes Study
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors Read more about A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer Read more about An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer